A detailed history of Nuveen Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 323,187 shares of BIIB stock, worth $48.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
323,187
Previous 321,308 0.58%
Holding current value
$48.2 Million
Previous $74.5 Million 15.89%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $355,262 - $444,947
1,879 Added 0.58%
323,187 $62.6 Million
Q2 2024

Aug 09, 2024

SELL
$190.52 - $236.72 $4.92 Million - $6.11 Million
-25,808 Reduced 7.43%
321,308 $74.5 Million
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $21.2 Million - $26.8 Million
-100,034 Reduced 22.37%
347,116 $74.8 Million
Q4 2023

Feb 14, 2024

SELL
$222.59 - $267.94 $30.2 Million - $36.3 Million
-135,603 Reduced 23.27%
447,150 $116 Million
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $6.04 Million - $6.82 Million
-23,851 Reduced 3.93%
582,753 $150 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $97,989 - $113,229
-356 Reduced 0.06%
606,604 $173 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $14.1 Million - $16.1 Million
54,975 Added 9.96%
606,960 $169 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $5.23 Million - $6.35 Million
-20,703 Reduced 3.62%
551,985 $153 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $12.9 Million - $17.8 Million
66,300 Added 13.09%
572,688 $153 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $3.21 Million - $3.82 Million
-17,122 Reduced 3.27%
506,388 $103 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $8.85 Million - $11.1 Million
-45,656 Reduced 8.02%
523,510 $108 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $321,996 - $413,813
-1,438 Reduced 0.25%
569,166 $137 Million
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $79 Million - $103 Million
-279,302 Reduced 32.86%
570,604 $161 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $5.85 Million - $9.37 Million
22,598 Added 2.73%
849,906 $294 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $18.5 Million - $21.6 Million
-76,002 Reduced 8.41%
827,308 $231 Million
Q4 2020

May 17, 2021

BUY
$236.26 - $355.63 $13.2 Million - $19.9 Million
56,009 Added 6.61%
903,310 $221 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $49.9 Million - $75.1 Million
211,105 Added 33.18%
847,301 $207 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $60.9 Million - $70.4 Million
-230,187 Reduced 26.57%
636,196 $180 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $37.5 Million - $49.7 Million
-145,063 Reduced 14.34%
866,383 $232 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $64.6 Million - $81.9 Million
-240,244 Reduced 19.19%
1,011,446 $320 Million
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $9.52 Million - $13.2 Million
43,275 Added 3.58%
1,251,690 $371 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $24.1 Million - $27 Million
-110,665 Reduced 8.39%
1,208,415 $281 Million
Q2 2019

Aug 15, 2019

BUY
$219.29 - $241.72 $242 Million - $266 Million
1,101,563 Added 506.43%
1,319,080 $308 Million
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $17.6 Million - $27.5 Million
80,994 Added 59.33%
217,517 $51.4 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $17.1 Million - $21.7 Million
61,473 Added 81.91%
136,523 $41.1 Million
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $2.81 Million - $3.68 Million
9,580 Added 14.63%
75,050 $26.5 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $21.2 Million - $25.3 Million
-82,338 Reduced 55.71%
65,470 $19 Million
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $2.03 Million - $2.87 Million
-7,813 Reduced 5.02%
147,808 $40.5 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $5.92 Million - $6.63 Million
19,239 Added 14.11%
155,621 $0
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $38.3 Million - $45 Million
136,382
136,382 $42.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.